Nursing and Health Professions
Patient
100%
Edoxaban
100%
Atrial Fibrillation
40%
Anticoagulation
40%
Percutaneous Endoscopic Gastrostomy
40%
Amyotrophic Lateral Sclerosis
30%
Follow up
20%
Antivitamin K
20%
Man
20%
Maximum Plasma Concentration
20%
Clinical Practice
10%
Morbidity
10%
Combination Therapy
10%
Hematuria
10%
Hypertension
10%
Heart Failure
10%
Bleeding
10%
Emergency Ward
10%
Thromboembolism
10%
International Normalized Ratio
10%
Rivaroxaban
10%
Acute Respiratory Failure
10%
Pharmacokinetic Parameters
10%
Clearance
10%
Half Life Time
10%
Dyspnea
10%
Takotsubo Cardiomyopathy
10%
Analysis
10%
Weight
10%
Time
10%
Dose
10%
Control
10%
Tachycardia
10%
Drug Administration
10%
Pill
10%
Acute Heart Failure
10%
Maximum Concentration
10%
Medicine and Dentistry
Edoxaban
100%
Atrial Fibrillation
40%
Anticoagulation
40%
Percutaneous Endoscopic Gastrostomy
40%
Amyotrophic Lateral Sclerosis
30%
Follow up
20%
Vitamin K Antagonist
20%
Steady State
20%
Inpatient
20%
Clinical Trial
20%
Heart Failure
10%
Maturity Onset Diabetes of the Young
10%
Dyspnea
10%
Combination Therapy
10%
Morbidity
10%
Hypertension
10%
Pharmacokinetics
10%
Rivaroxaban
10%
Thromboembolism
10%
Drug Administration
10%
Bleeding
10%
Tachyarrhythmia
10%
Acute Respiratory Failure
10%
Clearance
10%
Microhematuria
10%
Takotsubo Cardiomyopathy
10%
Acute Decompensated Heart Failure
10%
Analysis
10%
Plasma
10%
Pharmacology, Toxicology and Pharmaceutical Science
Edoxaban
100%
Atrial Fibrillation
40%
Normal Human
40%
Direct Oral Anticoagulant
40%
Amyotrophic Lateral Sclerosis
30%
Antivitamin K
20%
Pharmacokinetics
10%
Rivaroxaban
10%
Thromboembolism
10%
Hypertension
10%
Heart Failure
10%
Bleeding
10%
Morbidity
10%
Tachycardia
10%
Dyspnea
10%
Non Insulin Dependent Diabetes Mellitus
10%
Acute Heart Failure
10%
Acute Respiratory Failure
10%
Hematuria
10%
Takotsubo Cardiomyopathy
10%
Neuroscience
Edoxaban
100%
Atrial Fibrillation
40%
Amyotrophic Lateral Sclerosis
30%
Pharmacokinetics
20%
Anticoagulant
20%
Vitamin K Antagonist
20%
Hypertension
10%
Diabetes Mellitus
10%
Dyspnea
10%
Rivaroxaban
10%